Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury

Wei-Kun Zhao1, Yao Zhou2,3, Tong-Tong Xu1

  • 1Department of Health Care Ward, First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541001, China.

Insights

Ferroptosis, a cell death form driven by iron and reactive oxygen species (ROS), significantly impacts myocardial ischemia-reperfusion injury (MIRI). Understanding ferroptosis offers new therapeutic strategies for MIRI.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Medicine

Background:

  • Ferroptosis is a regulated cell death pathway dependent on iron and reactive oxygen species (ROS).
  • It involves lipid peroxidation, mitochondrial changes, and is linked to redox imbalance.
  • Myocardial ischemia-reperfusion injury (MIRI) is a critical complication of acute myocardial infarction.

Purpose of the Study:

  • To systematically review the mechanisms of ferroptosis.
  • To summarize the current understanding of ferroptosis's role in MIRI.
  • To explore potential therapeutic avenues for MIRI based on ferroptosis.

Main Methods:

  • Literature review of ferroptosis and MIRI research.
  • Analysis of studies investigating ferroptosis in cardiovascular contexts.
  • Synthesis of findings on ferroptosis inducers and inhibitors related to MIRI.

Main Results:

  • Ferroptosis induction leads to membrane damage via lipid peroxidation.
  • Accumulation of ROS and altered glutathione peroxidase (GPX) activity are key features.
  • Evidence suggests ferroptosis plays a significant role in the pathogenesis of MIRI.

Conclusions:

  • Ferroptosis is a critical factor in MIRI development.
  • Targeting ferroptosis pathways presents a promising strategy for MIRI treatment.
  • Further research into ferroptosis modulation could yield novel therapies for heart attack recovery.